Clinical Trial Update: A Pilot Study of XOMA 052 in Familial Cold Autoinflammatory Syndrome / Muckle-Wells Syndrome and Behcet's Disease [Phase 1, Phase 2]

View source ↗

Summary

A phase 1/2 study of XOMA 052 in familial cold autoinflammatory syndrome, Muckle-Wells syndrome, and Behçet's disease has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Behçet Disease
• Familial Cold Autoinflammatory Syndrome
• Muckle-wells Syndrome

Drugs mentioned

• XOMA 052

Snippet

Sponsor: National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) | Conditions: Muckle Wells Syndrome, Autoinflammatory | Phase 1, Phase 2 | Status: WITHDRAWN